Literature DB >> 21278759

Androgen deprivation therapy for prostate cancer: not so simple.

Nicholas N Tadros1, Mark Garzotto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21278759      PMCID： PMC3739209          DOI： 10.1038/aja.2010.174

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  6 in total

1.  Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.

Authors:  Shabbir M H Alibhai; Henriette Breunis; Narhari Timilshina; Calvin Johnston; George Tomlinson; Ian Tannock; Murray Krahn; Neil E Fleshner; Padraig Warde; Sarah Duff Canning; Lawrence Klotz; Gary Naglie
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

2.  Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer.

Authors:  Shabbir M H Alibhai; Henriette Breunis; Narhari Timilshina; Shireen Marzouk; Diane Stewart; Ian Tannock; Gary Naglie; George Tomlinson; Neil Fleshner; Murray Krahn; Padraig Warde; Sarah Duff Canning
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

3.  Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target.

Authors:  Yu Chen; Nicola J Clegg; Howard I Scher
Journal:  Lancet Oncol       Date:  2009-10       Impact factor: 41.316

Review 4.  Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review.

Authors:  Shabbir M H Alibhai; Sven Gogov; Zishan Allibhai
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-24       Impact factor: 6.312

5.  Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer.

Authors:  Maxwell V Meng; Gary D Grossfeld; Natalia Sadetsky; Shilpa S Mehta; Deborah P Lubeck; Peter R Carroll
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

Review 6.  Cognitive effects of hormone therapy in men with prostate cancer: a review.

Authors:  Christian J Nelson; Jennifer S Lee; Maria C Gamboa; Andrew J Roth
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860
  6 in total
  4 in total

Review 1.  Quality of life issues in men undergoing androgen deprivation therapy: a review.

Authors:  Rowan G Casey; Niall M Corcoran; S Larry Goldenberg
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

2.  Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks.

Authors:  Juan-Jie Bo; Chao Zhang; Lian-Hua Zhang; Ping Liu; Jian-Jun Sha; Jian-Wei Lv; Dong-Ming Liu; Yi-Ran Huang; Zheng Li
Journal:  Asian J Androl       Date:  2011-07-25       Impact factor: 3.285

Review 3.  Benefits and Consequences of Testosterone Replacement Therapy: A Review.

Authors:  Polackwich As; Tadros Nn; Ostrowski Ka; Hedges Jc
Journal:  Eur Endocrinol       Date:  2013-03-15

Review 4.  Autophagy in prostate cancer and androgen suppression therapy.

Authors:  Elio Ziparo; Simonetta Petrungaro; Elettra Sara Marini; Donatella Starace; Silvia Conti; Antonio Facchiano; Antonio Filippini; Claudia Giampietri
Journal:  Int J Mol Sci       Date:  2013-06-06       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.